A Novel Antibiotic Class Targeting the Lipopolysaccharide Transporter

Carbapenem-resistant Acinetobacter baumannii (CRAB) has emerged as a major global pathogen with limited treatment options. No new antibiotic chemical class with activity against A. baumannii has reached patients in over 50 years. Here we report the identification and optimization of tethered macrocyclic peptide (MCP) antibiotics with potent antibacterial activity against CRAB. The mechanism of action of this molecule class involves blocking the transport of bacterial lipopolysaccharide from the inner membrane to its destination on the outer membrane, through inhibition of the LptBFGC complex. A clinical candidate derived from the MCP class, zosurabalpin (RG6006), effectively treats highly drug-resistant contemporary isolates of CRAB both in vitro and in mouse models of infection, overcoming existing antibiotic resistance mechanisms. This chemical class represents a promising treatment paradigm for patients with invasive infections due to CRAB, for whom current treatment options are inadequate, and additionally identifies LptBFGC as a tractable target for antimicrobial drug development.

Citing Articles

Innovative perspectives on the discovery of small molecule antibiotics.

Cardona S, Rahman A, Novomisky Nechcoff J NPJ Antimicrob Resist. 2025; 3(1):19.

PMID: 40082593 PMC: 11906701. DOI: 10.1038/s44259-025-00089-0.

Advancing antibiotic discovery with bacterial cytological profiling: a high-throughput solution to antimicrobial resistance.

Salgado J, Rayner J, Ojkic N Front Microbiol. 2025; 16:1536131.

PMID: 40018674 PMC: 11865948. DOI: 10.3389/fmicb.2025.1536131.

HNP-1: From Structure to Application Thanks to Multifaceted Functions.

Zhang J, Liu Z, Zhou Z, Huang Z, Yang Y, Wu J Microorganisms. 2025; 13(2).

PMID: 40005828 PMC: 11858525. DOI: 10.3390/microorganisms13020458.

Complex Infections: New Treatment Options in the Antibiotic Pipeline.

Arshad N, Azzam W, Zilberberg M, Shorr A Microorganisms. 2025; 13(2).

PMID: 40005723 PMC: 11858728. DOI: 10.3390/microorganisms13020356.

Depth-Resolved Temperature-Dependent Penetration of Polymyxin B in Phospholipids/Lipopolysaccharide Asymmetric Bilayers.

Paracini N, Lakey J, Clifton L ACS Omega. 2025; 10(3):2616-2627.

PMID: 39895715 PMC: 11780448. DOI: 10.1021/acsomega.4c07648.

References

Kalil A, Metersky M, Klompas M, Muscedere J, Sweeney D, Palmer L . Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016; 63(5):e61-e111. PMC: 4981759. DOI: 10.1093/cid/ciw353. View

Hoveyda H, Marsault E, Gagnon R, Mathieu A, Vezina M, Landry A . Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): Development of ulimorelin (TZP-101) from hit to clinic. J Med Chem. 2011; 54(24):8305-20. DOI: 10.1021/jm2007062. View

Marsault E, Hoveyda H, Gagnon R, Peterson M, Vezina M, Saint-Louis C . Efficient parallel synthesis of macrocyclic peptidomimetics. Bioorg Med Chem Lett. 2008; 18(16):4731-5. DOI: 10.1016/j.bmcl.2008.06.085. View

Bolger A, Lohse M, Usadel B . Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014; 30(15):2114-20. PMC: 4103590. DOI: 10.1093/bioinformatics/btu170. View

Li J, Rayner C, Nation R, Owen R, Spelman D, Tan K . Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2006; 50(9):2946-50. PMC: 1563544. DOI: 10.1128/AAC.00103-06. View

Toprak E, Veres A, Yildiz S, Pedraza J, Chait R, Paulsson J . Building a morbidostat: an automated continuous-culture device for studying bacterial drug resistance under dynamically sustained drug inhibition. Nat Protoc. 2013; 8(3):555-67. PMC: 3708598. DOI: 10.1038/nprot.nprot.2013.021. View

Li H . A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data. Bioinformatics. 2011; 27(21):2987-93. PMC: 3198575. DOI: 10.1093/bioinformatics/btr509. View

Karakonstantis S, Kritsotakis E, Gikas A . Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options. J Antimicrob Chemother. 2019; 75(2):271-282. DOI: 10.1093/jac/dkz401. View

Okuda S, Freinkman E, Kahne D . Cytoplasmic ATP hydrolysis powers transport of lipopolysaccharide across the periplasm in E. coli. Science. 2012; 338(6111):1214-7. PMC: 3552488. DOI: 10.1126/science.1228984. View

10.

Leyn S, Zlamal J, Kurnasov O, Li X, Elane M, Myjak L . Experimental evolution in morbidostat reveals converging genomic trajectories on the path to triclosan resistance. Microb Genom. 2021; 7(5). PMC: 8209735. DOI: 10.1099/mgen.0.000553. View

11.

Nurk S, Bankevich A, Antipov D, Gurevich A, Korobeynikov A, Lapidus A . Assembling single-cell genomes and mini-metagenomes from chimeric MDA products. J Comput Biol. 2013; 20(10):714-37. PMC: 3791033. DOI: 10.1089/cmb.2013.0084. View

12.

Siguier P, Perochon J, Lestrade L, Mahillon J, Chandler M . ISfinder: the reference centre for bacterial insertion sequences. Nucleic Acids Res. 2005; 34(Database issue):D32-6. PMC: 1347377. DOI: 10.1093/nar/gkj014. View

13.

Chusri S, Chongsuvivatwong V, Silpapojakul K, Singkhamanan K, Hortiwakul T, Charernmak B . Clinical characteristics and outcomes of community and hospital-acquired Acinetobacter baumannii bacteremia. J Microbiol Immunol Infect. 2019; 52(5):796-806. DOI: 10.1016/j.jmii.2019.03.004. View

14.

Higgins P, Dammhayn C, Hackel M, Seifert H . Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2009; 65(2):233-8. DOI: 10.1093/jac/dkp428. View

15.

Peleg A, Seifert H, Paterson D . Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008; 21(3):538-82. PMC: 2493088. DOI: 10.1128/CMR.00058-07. View

16.

Schuster M, Brabet E, Oi K, Desjonqueres N, Moehle K, Le Poupon K . Peptidomimetic antibiotics disrupt the lipopolysaccharide transport bridge of drug-resistant Enterobacteriaceae. Sci Adv. 2023; 9(21):eadg3683. PMC: 10208570. DOI: 10.1126/sciadv.adg3683. View

17.

Trebosc V, Schellhorn B, Schill J, Lucchini V, Buhler J, Bourotte M . In vitro activity of rifabutin against 293 contemporary carbapenem-resistant Acinetobacter baumannii clinical isolates and characterization of rifabutin mode of action and resistance mechanisms. J Antimicrob Chemother. 2020; 75(12):3552-3562. PMC: 7662187. DOI: 10.1093/jac/dkaa370. View

18.

Owens T, Taylor R, Pahil K, Bertani B, Ruiz N, Kruse A . Structural basis of unidirectional export of lipopolysaccharide to the cell surface. Nature. 2019; 567(7749):550-553. PMC: 6629255. DOI: 10.1038/s41586-019-1039-0. View

19.

Nasr P . Genetics, epidemiology, and clinical manifestations of multidrug-resistant Acinetobacter baumannii. J Hosp Infect. 2019; 104(1):4-11. DOI: 10.1016/j.jhin.2019.09.021. View

20.

Simpson B, Pahil K, Owens T, Lundstedt E, Davis R, Kahne D . Combining Mutations That Inhibit Two Distinct Steps of the ATP Hydrolysis Cycle Restores Wild-Type Function in the Lipopolysaccharide Transporter and Shows that ATP Binding Triggers Transport. mBio. 2019; 10(4). PMC: 6703430. DOI: 10.1128/mBio.01931-19. View